Sobre 10 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Browse the full record of transactions filed by Schuetz Thomas J., Presidente y Director General. Director active across 1 company, notably Compass Therapeutics, Inc.. In total, 33 filings have been published. Breakdown: 22 buys · 0 sell. Total volume traded: €1.1m. History available since 16 November 2021. The latest transaction was filed on 8 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Schuetz Thomas J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20.000 títulos@ 2,34 US$1.0% de su flujoCommon StockSEC:0001171843-22-004408:0
Salida canónica: 14 sept 2022 (T+90)
25 de 33 declaraciones
About Schuetz Thomas J.
Schuetz Thomas J. is President and Chief Executive Officer of Compass Therapeutics, Inc. (XNAS). He has 33 filings in total, and across the 33 sampled filings, the transactions recorded are acquisitions, with EUR 1116072 of buys and EUR 0 of sells, over the period from 2021-11-18 to 2026-02-10.